FI91876B - Method for preparing amino acid derivatives having a nootropic effect - Google Patents

Method for preparing amino acid derivatives having a nootropic effect

Info

Publication number
FI91876B
FI91876B FI871304A FI871304A FI91876B FI 91876 B FI91876 B FI 91876B FI 871304 A FI871304 A FI 871304A FI 871304 A FI871304 A FI 871304A FI 91876 B FI91876 B FI 91876B
Authority
FI
Finland
Prior art keywords
amino acid
acid derivatives
preparing amino
nootropic effect
nootropic
Prior art date
Application number
FI871304A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI871304A (en
FI871304A0 (en
FI91876C (en
Inventor
Franz Hock
Josef Scholtholt
Hansjoerg Urbach
Rainer Henning
Ulrich Lerch
Wolf-Ulrich Nickel
Wolfgang Rueger
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI871304A0 publication Critical patent/FI871304A0/en
Publication of FI871304A publication Critical patent/FI871304A/en
Application granted granted Critical
Publication of FI91876B publication Critical patent/FI91876B/en
Publication of FI91876C publication Critical patent/FI91876C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
  • Epoxy Compounds (AREA)

Abstract

The invention relates to novel compounds having a nootropic activity, the use of ACE inhibitors as medicaments having nootropic activity, agents containing them, and their use in the treatment and prophylaxis of cognitive malfunctions.
FI871304A 1986-03-27 1987-03-25 Method for preparing amino acid derivatives having a nootropic effect FI91876C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3610391 1986-03-27
DE19863610391 DE3610391A1 (en) 1986-03-27 1986-03-27 COMPOUNDS WITH NOOTROPPER ACTION, THESE CONTAINERS AND THEIR USE IN THE TREATMENT AND PROPHYLAXIS OF COGNITIVE DYSFUNCTIONS

Publications (4)

Publication Number Publication Date
FI871304A0 FI871304A0 (en) 1987-03-25
FI871304A FI871304A (en) 1987-09-28
FI91876B true FI91876B (en) 1994-05-13
FI91876C FI91876C (en) 1994-08-25

Family

ID=6297417

Family Applications (1)

Application Number Title Priority Date Filing Date
FI871304A FI91876C (en) 1986-03-27 1987-03-25 Method for preparing amino acid derivatives having a nootropic effect

Country Status (25)

Country Link
EP (1) EP0243645B1 (en)
JP (1) JPS62240698A (en)
KR (1) KR870008841A (en)
CN (1) CN1031267C (en)
AT (1) ATE102954T1 (en)
AU (1) AU621278B2 (en)
CA (1) CA1341064C (en)
CS (2) CS651989A3 (en)
DD (1) DD280765A5 (en)
DE (2) DE3610391A1 (en)
DK (1) DK172221B1 (en)
EG (1) EG18175A (en)
ES (1) ES2061447T3 (en)
FI (1) FI91876C (en)
HU (2) HU203117B (en)
IE (1) IE62456B1 (en)
MA (1) MA20919A1 (en)
NO (1) NO178546C (en)
NZ (1) NZ219764A (en)
OA (1) OA08506A (en)
PH (1) PH27210A (en)
PT (1) PT84564B (en)
RU (1) RU1836335C (en)
TN (1) TNSN87045A1 (en)
ZA (1) ZA872230B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231084A (en) * 1986-03-27 1993-07-27 Hoechst Aktiengesellschaft Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
AU612137B2 (en) * 1987-04-27 1991-07-04 E.R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing an ace inhibitor
DE3731085A1 (en) * 1987-09-16 1989-04-06 Hoechst Ag NEW AMINO ACID ESTERS, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THE USE THEREOF
DE3739690A1 (en) * 1987-11-24 1989-06-08 Hoechst Ag STABILIZED MEDICINAL PRODUCTS, METHOD FOR THEIR PRODUCTION AND STABLE MEDICAL PREPARATIONS
DE3801587A1 (en) * 1988-01-21 1989-08-03 Hoechst Ag NEW AMINO ACID GLYCERIDES, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THE USE THEREOF
EP0331609A3 (en) * 1988-01-27 1992-07-01 Hoechst Aktiengesellschaft Angiotensin converting enzyme inhibitors having psychotropic effects
DE3803225A1 (en) * 1988-02-04 1989-08-17 Hoechst Ag AMINO ACID AMIDE WITH PSYCHOTROPIC EFFECT, METHOD FOR THE PRODUCTION THEREOF, AGENTS CONTAINING THE SAME AND THEIR USE
JPH01275529A (en) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc Suppressing treatment agent of delayed motion effect
US5037821A (en) * 1988-06-01 1991-08-06 E. R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor
US5093129A (en) * 1989-01-30 1992-03-03 E. R. Squibb & Sons, Inc. Method for treating addiction to a drug of abuse employing an ace inhibitor
US5032578A (en) * 1990-09-17 1991-07-16 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
JP2004532200A (en) * 2001-03-15 2004-10-21 サエジス ファーマシューティカルズ， インコーポレイテッド Methods for restoring cognitive function after systemic stress

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19575012I2 (en) * 1980-10-23 2002-01-24 Schering Corp Carboxyalkyl dipeptides Process for their preparation and medicaments containing them
DE3300774A1 (en) * 1983-01-12 1984-07-12 Hoechst Ag, 6230 Frankfurt NEW SPIROCYCLIC AMINO ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF AND NEW SPIROCYCLIC AMINO ACIDS AS INTERMEDIATE PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
CS212687A3 (en) 1992-04-15
NZ219764A (en) 1990-11-27
PT84564B (en) 1989-11-10
HU896609D0 (en) 1990-02-28
ES2061447T3 (en) 1994-12-16
NO871282L (en) 1987-09-28
EP0243645A2 (en) 1987-11-04
DE3789330D1 (en) 1994-04-21
DK153587D0 (en) 1987-03-26
ZA872230B (en) 1987-09-21
AU7064987A (en) 1987-10-01
IE62456B1 (en) 1995-02-08
OA08506A (en) 1988-07-29
NO871282D0 (en) 1987-03-26
CS276385B6 (en) 1992-05-13
FI871304A (en) 1987-09-28
EG18175A (en) 1994-07-30
CN1031267C (en) 1996-03-13
DK172221B1 (en) 1998-01-12
HU202118B (en) 1991-02-28
KR870008841A (en) 1987-10-21
MA20919A1 (en) 1987-10-01
CA1341064C (en) 2000-08-01
IE870784L (en) 1987-09-27
JPS62240698A (en) 1987-10-21
ATE102954T1 (en) 1994-04-15
CS276179B6 (en) 1992-04-15
CS651989A3 (en) 1992-05-13
DD280765A5 (en) 1990-07-18
NO178546B (en) 1996-01-08
PH27210A (en) 1993-05-04
RU1836335C (en) 1993-08-23
EP0243645B1 (en) 1994-03-16
HU203117B (en) 1991-05-28
NO178546C (en) 1996-04-17
EP0243645A3 (en) 1990-01-24
FI871304A0 (en) 1987-03-25
CN87102304A (en) 1987-12-30
PT84564A (en) 1987-04-01
TNSN87045A1 (en) 1990-01-01
FI91876C (en) 1994-08-25
AU621278B2 (en) 1992-03-12
DK153587A (en) 1987-09-28
DE3610391A1 (en) 1987-10-08
HUT46046A (en) 1988-09-28

Similar Documents

Publication Publication Date Title
IL104154A0 (en) Saccharin derivatives,their preparation and pharmaceutical compositions containing them
EP0201742A3 (en) N-acylpyrrolidine derivatives, processes for preparing them, pharmaceutical composition and use
FI91876B (en) Method for preparing amino acid derivatives having a nootropic effect
DK92786D0 (en) LABDANES, METHOD OF PREPARING THEREOF AND THEIR USE AS MEDICINES
EP0471756A4 (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
HUT51298A (en) Process for producing retarde hirudine derivatives and pharmaceutical compositions containing them as active components
ATE67756T1 (en) N-SUBSTITUTED 3-PIPERIDINE OR 3PYRIDINE CARBONIC ACURES AND THEIR DERIVATIVES.
HUT45081A (en) Process for producing amino acid derivatives and pharmaceuticals comprising these compounds as active ingredient
ATE75399T1 (en) THERAPEUTIC FOR TREATMENT OF STOMACH ULCERS.
PT91415A (en) METHOD FOR THE PREPARATION OF NEW FURILTIAZOLE DERIVATIVES
PT88242A (en) PROCESS FOR THE PREPARATION OF ETEREYS AND THIOETERS HAVING THERAPEUTIC ACTIVITY
DE3687895D1 (en) ARGININE AND AGMATINE DERIVATIVES FOR TREATING PROTOZOE INFECTIONS.

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: AVENTIS PHARMA DEUTSCHLAND GMBH

PC Transfer of assignment of patent

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH

Free format text: SANOFI-AVENTIS DEUTSCHLAND GMBH

MA Patent expired